IBDEI1G9 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24212,1,3,0)
 ;;=3^Type 1 DM w/ Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,24212,1,4,0)
 ;;=4^E10.42
 ;;^UTILITY(U,$J,358.3,24212,2)
 ;;=^5002606
 ;;^UTILITY(U,$J,358.3,24213,0)
 ;;=E13.42^^116^1189^1
 ;;^UTILITY(U,$J,358.3,24213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24213,1,3,0)
 ;;=3^Secondary Type DM w/ Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,24213,1,4,0)
 ;;=4^E13.42
 ;;^UTILITY(U,$J,358.3,24213,2)
 ;;=^5002686
 ;;^UTILITY(U,$J,358.3,24214,0)
 ;;=E10.621^^116^1189^3
 ;;^UTILITY(U,$J,358.3,24214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24214,1,3,0)
 ;;=3^Type 1 DM w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,24214,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,24214,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,24215,0)
 ;;=E10.649^^116^1189^5
 ;;^UTILITY(U,$J,358.3,24215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24215,1,3,0)
 ;;=3^Type 1 DM w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,24215,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,24215,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,24216,0)
 ;;=E11.621^^116^1189^8
 ;;^UTILITY(U,$J,358.3,24216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24216,1,3,0)
 ;;=3^Type 2 DM w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,24216,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,24216,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,24217,0)
 ;;=E11.649^^116^1189^10
 ;;^UTILITY(U,$J,358.3,24217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24217,1,3,0)
 ;;=3^Type 2 DM w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,24217,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,24217,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,24218,0)
 ;;=99080^^117^1190^7^^^^1
 ;;^UTILITY(U,$J,358.3,24218,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24218,1,2,0)
 ;;=2^99080
 ;;^UTILITY(U,$J,358.3,24218,1,3,0)
 ;;=3^SPECIAL REPORTS OR FORMS
 ;;^UTILITY(U,$J,358.3,24219,0)
 ;;=97535^^117^1190^6^^^^1
 ;;^UTILITY(U,$J,358.3,24219,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24219,1,2,0)
 ;;=2^97535
 ;;^UTILITY(U,$J,358.3,24219,1,3,0)
 ;;=3^SELF CARE MNGMENT TRAINING
 ;;^UTILITY(U,$J,358.3,24220,0)
 ;;=99366^^117^1190^8^^^^1
 ;;^UTILITY(U,$J,358.3,24220,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24220,1,2,0)
 ;;=2^99366
 ;;^UTILITY(U,$J,358.3,24220,1,3,0)
 ;;=3^TEAM CONF W/PAT BY HC PRO
 ;;^UTILITY(U,$J,358.3,24221,0)
 ;;=A9279^^117^1190^5^^^^1
 ;;^UTILITY(U,$J,358.3,24221,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24221,1,2,0)
 ;;=2^A9279
 ;;^UTILITY(U,$J,358.3,24221,1,3,0)
 ;;=3^MONITORING FEATURE/DEVICE NOC
 ;;^UTILITY(U,$J,358.3,24222,0)
 ;;=H0034^^117^1190^4^^^^1
 ;;^UTILITY(U,$J,358.3,24222,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24222,1,2,0)
 ;;=2^H0034
 ;;^UTILITY(U,$J,358.3,24222,1,3,0)
 ;;=3^MED TRNG & SUPPORT PER 15MIN
 ;;^UTILITY(U,$J,358.3,24223,0)
 ;;=S9455^^117^1190^1^^^^1
 ;;^UTILITY(U,$J,358.3,24223,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24223,1,2,0)
 ;;=2^S9455
 ;;^UTILITY(U,$J,358.3,24223,1,3,0)
 ;;=3^DIAB MANAGE TRN GROUP
 ;;^UTILITY(U,$J,358.3,24224,0)
 ;;=S9445^^117^1190^2^^^^1
 ;;^UTILITY(U,$J,358.3,24224,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24224,1,2,0)
 ;;=2^S9445
 ;;^UTILITY(U,$J,358.3,24224,1,3,0)
 ;;=3^DIAB MANAGE TRN PER INDIV
 ;;^UTILITY(U,$J,358.3,24225,0)
 ;;=S9446^^117^1190^3^^^^1
 ;;^UTILITY(U,$J,358.3,24225,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24225,1,2,0)
 ;;=2^S9446
 ;;^UTILITY(U,$J,358.3,24225,1,3,0)
 ;;=3^GROUP HEALTH EDUCATION
 ;;^UTILITY(U,$J,358.3,24226,0)
 ;;=S9445^^117^1191^1^^^^1
 ;;^UTILITY(U,$J,358.3,24226,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,24226,1,2,0)
 ;;=2^S9445
 ;;^UTILITY(U,$J,358.3,24226,1,3,0)
 ;;=3^PT EDUCATION NOC INDIV
